INDSWFTLAB - Ind-Swift Laboratories

Ind-Swift Laboratories

INDSWFTLAB · Pharma > Pharmaceuticals & Drugs · Chairman: N R Munjal · MD: N R Munjal · Listing date: July 17, 1997 · Employees: 1531 · Chandigarh · http://www.indswiftlabs.com

Stock Price vs Company Growth

1.7%

4.2%

17.6%

5.1%

1.8%

40.7%

25.3%

10y

13.1%

all

5.4%

🤔 How to analyze this graph?

Last Traded Price

₹ 126 1.7%

123

186

Company Overview

Sales

1,004 Cr

Growth: 9.6%

Profit after Tax

-95.8 Cr

Growth: 20.5%

Small Cap

746 Cr

P/E: 2.6x

Industry P/E: 41.4x

Fundamentals

Sales (Cr)	₹ 1,004
Growth	9.6%
EBITDA	7.0%
P/S	0.7x
Dividend	0.0%
P/E	2.6x
Book Value	₹ 158
PEG Ratio	0.3x
ROE	-12.9%
P/B	0.8x

Shareholding Pattern

Institutions

Edelweiss India Special Situations Fund Ii

10.43 %

Ec Special Situations Fund

6.82 %

Ashokkumar Chandak

2.79 %

Eisaf Ii Onshore Fund

2.24 %

Sri Ganesh Biotech Private Limited

1.26 %

Promoters

Essix Biosciences Limited

21.71 %

Ind Swift Ltd

16.08 %

N.R. Munjal

1.56 %

Rishav Mehta

0.77 %

Himanshu Jain

0.69 %

Others

Increase Decrease No change

Company Profile Detailed

Ind-Swift Laboratories is a part of the Ind-swift Group and is based at Chandigarh, India. It has been promoted by Ind-Swift Limited in a joint venture with the Punjab State Industrial Development Corporation Limited (PSIDC). The group has established a strong reputation as innovators in the Indian pharmaceutical industry. Ind-Swift Laboratories Ltd. went public in 1997 and concentrated on the manufacturing of Active Pharmaceutical Ingredients (API).

Investors (112)

essix.bi...

nivl.adv...

iepf

Followers (1)

murali5